How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
In just a few years, exosomes have started gaining recognition as a solution to deliver…
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
High-value metals make the modern world go round, but the way we extract and dispose…
Gene therapy is a hot area in the biotech industry right now, with many treatments…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
Sometimes in biotech, when your standard E. coli just won't cut it, something more exotic…
As Europe moves to reduce its reliance on agrochemicals in the farming system over the…
Scouring the natural world can be an effective way of finding design inspiration for new…
The first RNA interference therapy was approved in 2018, after 20 years in development. What…
With dire climate change reports landing one after another in 2018 the need for sustainable,…
With the rise of antimicrobial resistance across the globe, and with a dire lack of…